Protection of non-murine mammals against encephalomyocarditis virus using a genetically engineered Mengo virus

Jorge E. Osorio, Gene B. Hubbard, Kenneth F. Soike, Marc Girard, Sylvie Van Der Werf, Jean Claude Moulin, Ann C. Palmenberg

Research output: Contribution to journalArticlepeer-review

19 Scopus citations


Genetically engineered Mengo viruses with artificial deletions in the 5' noncoding poly(C) tracts are highly attenuated for pathogenicity when introduced as live vaccines into the natural murine host. Inoculation produces lifelong protective immunity without disease or viral persistence. This report extends the vaccination studies to non-murine hosts, including baboons, macaques and domestic pigs, all of which are susceptible to severe cardiovirus epizootics. All animals of these species that were inoculated with vMC24, an engineered strain of Mengo, seroconverted. When the immunized animals were challenged, they were protected against lethal doses of encephalomyocarditis virus (EMCV) derived from currently circulating epizootic strains. In baboons, the neutralizing antibody titers induced by vMC24 were significantly higher than from an inactivated EMCV vaccine. Moreover, terminal histopathology on baboons (inoculated intramuscularly), macaques (inoculated intracerebrally), and pigs (inoculated intramuscularly) showed few, if any, gross lesions characteristic of EMCV-like disease, in the vMC24 vaccinates. We suggest that genetically engineered, short poly(C) Mengo viruses may be universally potent attenuated vaccines for many types of animals and can possibly provide safe, efficacious protection against all cardioviruses of the EMCV serotype.

Original languageEnglish (US)
Pages (from-to)155-161
Number of pages7
Issue number2
StatePublished - Feb 1996
Externally publishedYes


  • Attenuated EMCV vaccine
  • Genetically engineered mutant
  • Mengo virus

ASJC Scopus subject areas

  • Molecular Medicine
  • Immunology and Microbiology(all)
  • veterinary(all)
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases


Dive into the research topics of 'Protection of non-murine mammals against encephalomyocarditis virus using a genetically engineered Mengo virus'. Together they form a unique fingerprint.

Cite this